oxprenolol has been researched along with Diseases, Metabolic in 1 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walldius, G | 1 |
1 other study available for oxprenolol and Diseases, Metabolic
| Article | Year |
|---|---|
What happens after lipoprotein lipase? A low fatty acid incorporation into adipose tissue (FIAT) in hypertriglyceridaemia-experimental and clinical studies.
Topics: Adipose Tissue; Adult; Aged; Clofibrate; Fatty Acids; Glucose; Humans; Lipolysis; Lipoprotein Lipase | 1981 |